Table 2.
|
Standard treatment group (n = 50) |
Anti-TNF agents group (n = 41) |
Group-differences |
||||
---|---|---|---|---|---|---|---|
Mean (S.D.) | Median | Mean (S.D.) | Median | Mann–Whitney U-test | p-values | Effect sizes (r) | |
Arthritis activity: Composite disease activity score |
2.8 (2.5) |
2.00 |
0.65 (1.00) |
0.00 |
Z = −4.51 |
<0.001 |
0.47 |
Functional disability: CHAQ dis. index |
0.25 (0.37) |
0.10 |
0.30 (0.32) |
0.10 |
Z = −0.01 |
0.99 |
0.001 |
Pain intensity: Mean pain diary score |
0.86 (0.88) |
0.60 |
1.03 (1.19) |
0.69 |
Z = −0.49 |
0.62 |
0.05 |
|
Number (%) |
Number (%) |
Chi2-test |
p-values |
Effect sizes (phi) |
||
Patients with no pain reported in the pain diary |
1 (2.0%) |
13 (31.7%) |
χ2(1) = 15.27 |
<0.001 |
0.41 |
||
Patients with daily pain reported in the pain diary | 12 (24.0%) | 12 (29.3%) | χ2(1) = 0.32 | 0.64 | 0.06 |